Affiliation:
1. Business School, Koneru Lakshmaiah Education Foundation (Deemed), India
2. Odisha State Open University, India
Abstract
The convergence of telemedicine and artificial intelligence (AI) technology has ushered in a transformative era in pharmacology. AI algorithms, capable of analysing extensive patient data, enable early detection of deterioration, timely intervention, accurate predictions, and personalized treatment recommendations. This chapter examines the exponential growth of AI technology and its integration into pharmacology, offering insights into decision-making processes surrounding the adoption, implementation, and scaling of AI-driven telemedicine solutions. Through a comprehensive review, it underscores the benefits of AI-based pharma core technology integration into telemedicine, supported by keyword analysis from the Web of Science database. The study concludes that the fusion of pharmacology and AI represents a progressive advancement, particularly in biochemistry, medicine, and health sectors.